Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer
Martijn J.H.G. Simons, Valesca P. Retèl, Bram L.T. Ramaekers, Rogier Butter, Joanne M. Mankor, Marthe S. Paats, Joachim G.J.V. Aerts, Zakile A. Mfumbilwa, Paul Roepman, Veerle M.H. Coupé, Carin A. Uyl-de Groot, Wim H. van Harten, Manuela A. Joore*
Dive into the research topics of 'Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer'. Together they form a unique fingerprint.